Taubman Institute Symposium to take place Oct. 11 in Ann Arbor

The A. Alfred Taubman Medical Research Institute presents its sixth annual symposium, featuring the presentation of the $100,000 Taubman Prize by Mr. A. Alfred Taubman, from 10 a.m. to noon on Oct. 11.  The event takes place in the Kahn Auditorium of the A. Alfred Taubman Biomedical Science Research Building on the University of Michigan campus. 

The co-recipients of the Taubman Prize, Dr. Brian Druker and Dr. Charles Sawyers, will deliver keynote addresses about their live-saving research that transformed chronic myeloid leukemia from an always-fatal disease to a manageable condition.   A poster session will precede the symposium beginning at 8:30 a.m.   No registration is required; both events are free and open to the general public. 

Click here for directions to the A. Alfred Taubman Biomedical Science Research Building. 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift


Follow Us / Friend Us

Discovery-driven research that matters


Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding


The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more

Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  


Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster


video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists